Parekh Rulan S, Flynn Joseph T, Smoyer William E, Milne Joan L, Kershaw David B, Bunchman Timothy E, Sedman Aileen B
Departments of Pediatrics and Medicine, Johns Hopkins University, Baltimore, Maryland.
Department of Pediatrics, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York.
J Am Soc Nephrol. 2001 Nov;12(11):2418-2426. doi: 10.1681/ASN.V12112418.
Growth in children with chronic renal failure caused by polyuric, salt-wasting diseases may be hampered if ongoing sodium and water losses are not corrected. Twenty-four children were treated with polyuric chronic renal insufficiency (CRI; creatinine clearance <65 ml/min per 1.73 m(2)) with low-caloric-density, high-volume, sodium-supplemented feedings. Subsequent growth was compared with that of children in two control groups: a national historic population control from the US Renal Data System database (n = 42), and a literature control (n = 12). Members of the three groups were 81 to 96% white, and 58 to 70% were boys. Obstructive uropathy and dysplasia were the cause of CRI in 92% of the treatment group, 75% of the literature control group, and 30% of the population control group. Treatment effect was assessed in a multivariate, retrospective analysis of the height standard deviation score (SDS), simultaneously controlling for the severity of disease by renal replacement therapy, primary cause of CRI, and initial height SDS. The change in SDS (Delta SDS) for height by regression analysis at 1 yr was significantly greater by +1.37 in the treatment group versus the population control (P = 0.017). The 2-yr height Delta SDS by regression analysis adjusted for creatinine clearance was significantly greater by +1.83 in the treatment group versus the literature control (P = 0.003). Nutritional support with sodium and water supplementation can maintain or improve the growth of children with polyuric, salt-wasting CRI. This inexpensive intervention may delay the need for renal replacement therapy, growth hormone treatment, or both in many of these children and may be used in any clinical setting.
如果持续的钠和水流失得不到纠正,由多尿、失盐性疾病引起的慢性肾衰竭儿童的生长可能会受到阻碍。24名患有多尿性慢性肾功能不全(CRI;肌酐清除率<65 ml/min per 1.73 m(2))的儿童接受了低热量密度、高容量、补充钠的喂养。随后将其生长情况与两个对照组儿童的生长情况进行比较:一个是来自美国肾脏数据系统数据库的全国历史性人群对照组(n = 42),另一个是文献对照组(n = 12)。三组成员中81%至96%为白人,58%至70%为男孩。梗阻性尿路病和发育异常是治疗组92%、文献对照组75%和人群对照组30%的CRI病因。在对身高标准差评分(SDS)进行多变量回顾性分析中评估治疗效果,同时通过肾脏替代治疗、CRI的主要病因和初始身高SDS来控制疾病的严重程度。通过回归分析,治疗组1年时身高的SDS变化(Delta SDS)比人群对照组显著增加+1.37(P = 0.017)。在根据肌酐清除率进行调整后,治疗组2年时身高的Delta SDS通过回归分析比文献对照组显著增加+1.83(P = 0.003)。补充钠和水的营养支持可以维持或改善患有多尿、失盐性CRI儿童的生长。这种低成本的干预措施可能会延迟许多此类儿童对肾脏替代治疗、生长激素治疗或两者的需求,并且可用于任何临床环境。